Lupin recalls

Lupin Pharmaceuticals is recalling specific lots of Clobetasol Propionate Cream USP 0.05% because the active ingredient is not uniformly distributed throughout the product. This means some parts of the cream may contain too much or too little medication, which could affect how well it works.

Moderate·FDA·Sep 2, 2026

Lupin Pharmaceuticals is recalling multiple lots of prednisolone acetate ophthalmic suspension 1% (an anti-inflammatory eye drop) due to the presence of a foreign substance in some bottles. The affected lots were distributed nationwide. No injuries have been reported.

Moderate·FDA·Jul 8, 2026

Lupin Pharmaceuticals is recalling certain lots of its Glucagon Emergency Kit because the syringe plunger may not move smoothly during use. This defect was discovered during stability testing and could prevent the kit from working properly in an emergency.

Moderate·FDA·Jul 8, 2026

Lupin Pharmaceuticals is recalling certain batches of Liraglutide Injection (a diabetes and weight-loss medication) because white thread-like particles have been found inside the cartridges. The affected pens are distributed nationwide. No injuries have been reported.

Moderate·FDA·May 27, 2026

Defective container - seal not adhering to bottles

FDA·Dec 17, 2025

Failed impurities/degradation specifications: out of specification results for Ganirelix acetate acrylic acid adduct impurity.

FDA·Dec 17, 2025